TNF and neoplasm: Molecular-genetic imaging is currently not possible with targeted AAVP-TNF vectors, so routine clinical MRI or PET/CT would have to be used in parallel with cytotoxic therapy to evaluate tumor response over time without a corresponding measurement of transgene expression.